Literature DB >> 15802163

Genetic susceptibility to pneumonia.

Grant W Waterer1, Richard G Wunderink.   

Abstract

The persistent mortality from community-acquired pneumonia may be explained by genetic predisposition. Specific mutations or polymorphisms in host response genes that are associated with adverse outcomes from infection can be grouped into four categories: antigen recognition, proinflammatory responses, anti-inflammatory responses, and effector mechanisms. Mannose-binding lectin polymorphisms have a more dominant role in pneumonia when compared with other pattern recognition molecules such as the toll-like receptors. The roles of TNF and lymphotoxin alpha polymorphisms remain unclear despite extensive study. IL-10 and IL-1 receptor antagonist polymorphisms have an important role in the anti-inflammatory response. Specific organ dysfunction, such as ARDS or DIC, may be related to polymorphisms in specific effector genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802163     DOI: 10.1016/j.ccm.2004.10.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  5 in total

Review 1.  Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

2.  Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.

Authors:  Jairam R Lingappa; Logan Dumitrescu; Shanta M Zimmer; Ruth Lynfield; Janet M McNicholl; Nancy E Messonnier; Cynthia G Whitney; Dana C Crawford
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

3.  Association between TLR4 A299G polymorphism and pneumonia risk: a meta-analysis.

Authors:  Xingjun Cai; Yihui Fu; Qingyun Chen
Journal:  Med Sci Monit       Date:  2015-02-27

4.  Mannose-binding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens.

Authors:  Gijs van Kempen; Sabine Meijvis; Henrik Endeman; Bart Vlaminckx; Bob Meek; Ben de Jong; Ger Rijkers; Willem Jan Bos
Journal:  Immunology       Date:  2017-01-24       Impact factor: 7.397

Review 5.  [Community acquired pneumonia CAP].

Authors:  Christoph Wenisch; Christine M Bonelli
Journal:  Wien Klin Wochenschr       Date:  2006-12       Impact factor: 1.704

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.